Moderna COVID-19 Vaccine, Bivalent
is now authorized
The updated booster from Moderna is designed to help protect against multiple COVID-19 variants in a single shot.
What is a Bivalent Vaccine?
Bivalent vaccines are designed to protect against 2 strains of a virus providing greater protection against variants.
Why should patients get a Bivalent Vaccine?
A bivalent is recommended because it's the only type of vaccine that can protect against the most dominant Omicron strains of COVID-19 in the US.
With the rise of more contagious variants, people need greater protection, even with prior vaccination or immunity from COVID-19 infection.
Vaccine Overview for
Adult Primary Series Vaccination
Looking for information on adult primary series vaccination?Visit HCP site for spikevax
(COVID‑19 vaccine, mRNA)
Dosing and Administration
The Moderna COVID‑19 Vaccine is administered as a primary series by intramuscular injection of two doses (0.5 mL each) 1 month apart to individuals 6 years of age or older or two doses (0.25 mL each) 1 month apart to individuals 6 months-5 years of age.
A third primary series dose of the Moderna COVID‑19 Vaccine (0.5 mL or 0.25 mL, depending on age) at least 1 month following the second dose is authorized for administration to individuals at least 6 months of age who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.
Bivalent Booster Dosing and Administration
Moderna COVID‑19 Vaccine, Bivalent is administered in individuals 6 years of age and older as a single booster dose at least 2 months after:
- Completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine
- Receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine
Clinical Trial Data
In five clinical trials, approximately 40,000 participants aged 6 months and older received at least one dose of Moderna COVID-19 Vaccine.See clinical trial data